NCT05611203 is a NA clinical trial of An Oropharyngeal swab in SARS-CoV Infection, sponsored by Rigshospitalet, Denmark.

Who is sponsoring NCT05611203?

NCT05611203 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT05611203?

Interventions in NCT05611203: An Oropharyngeal swab.

What condition does NCT05611203 study?

NCT05611203 studies SARS-CoV Infection, Coronavirus, Corona Virus Infection.

Is NCT05611203 still recruiting?

NCT05611203 is currently status unknown. Last updated 11 January 2023.

Last reviewed 2023-01-11 · How we verify

NCT05611203

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing?

Status unknown NA Last updated 11 January 2023

What this trial tests

NA trial testing An Oropharyngeal swab in SARS-CoV Infection in 1,000 participants. Status unknown.

Timeline

10 November 2022

Primary endpoint
30 January 2023

2 March 2023

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	1,000
Start date	10 November 2022
Primary completion	30 January 2023
Estimated completion	2 March 2023
Sites	2 locations across Denmark

Drugs / interventions tested

An Oropharyngeal swab

Conditions studied

SARS-CoV Infection — all drugs for SARS-CoV Infection →
Coronavirus — all drugs for Coronavirus →
Corona Virus Infection — all drugs for Corona Virus Infection →

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with SARS-CoV Infection or Coronavirus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Citizens who undergo testing for COVID-19 at one of two Testcenters in Copenhagen Captial Region will be invited to participate in the study. The participants will be randomized to either an oropharyngeal swap including the palatine tonsils OR an oropharyngeal swap without the palatine tonsils for SARS-CoV-2 testing. The swabs will be sent to the clinical microbiology laboratory for SARS-CoV-2 detection using RT-PCR. The diagnostic accuracy and SARS-CoV-2 viral load will be compared. The participants will be asked to complete a questionnaire regarding their symptoms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Molecular Detection of SARS-CoV-2 From Throat Swabs Performed With or Without Specimen Collection From the Tonsils: Protocol for a Multicenter Randomized Controlled Trial.
Hartvigsen B, Jakobsen KK, Benfield T, Gredal NT, et al · · 2024 · cited 1× · PMID 38865190 · DOI 10.2196/47446

Verify or expand the search:

Other recruiting trials for SARS-CoV Infection

Currently open trials in the same condition.

NCT05886816 — Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 · Phase 2 · recruiting
NCT04802408 — SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial · Phase 2, PHASE3 · active not recruiting
NCT04815096 — Imaging Immune Activation in COVID-19 · Phase 2 · recruiting
NCT04747522 — Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) · active not recruiting
NCT04579471 — Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05611203 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 11 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05611203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing